Efficacy and Adverse Event Profile of the iStent and iStent Inject Trabecular Micro-bypass for Open-angle Glaucoma: A Meta-analysis
Open Access
- 1 January 2018
- journal article
- review article
- Published by Jaypee Brothers Medical Publishing in Journal of Current Glaucoma Practice
- Vol. 12 (2) , 67-84
Abstract
This meta-analysis explores the efficacy and adverse event profile of the iStent, an ab interno implant for the treatment of open-angle glaucoma. A systematic literature search of Ovid MEDLINE and EMBASE was used to identify peer-reviewed original studies that provided efficacy data on the first or second generation iStent for at least five eyes. Intraocular pressure (IOP) was the primary efficacy endpoint, while the number of medication classes was the secondary outcome. Weighted mean differences were reported for continuous endpoints, while a relative risk was computed for dichotomous variables. The search revealed 545 results, of which 1767 eyes from 28 studies were included. The cohort age was 71.4 ± 5.4 years, and 44.9% of patients were male. There was a significantly greater IOP reduction after the use of two first-generation stents compared to one, irrespective of phacoemulsification status (p < 0.001). Additionally, there was a significantly greater IOP reduction following iStent alone relative to phaco-iStent for the first-generation iStent (p < 0.001) and the iStent inject (p < 0.001). For the first generation stent, combined phaco-iStent provided a greater level of IOP reduction (p < 0.001) and reduction in the number of medication classes relative to phacoemulsification alone (p < 0.001). In total, 22.5% of eyes that received iStent implantation sustained some type of adverse event. The most common adverse events were intraocular pressure elevation, stent blockage or obstruction, stent malposition and hyphema. Statistically significant differences in efficacy outcomes exist between different numbers of stents and the presence or absence of concurrent phacoemulsification. How to cite this article: Popovic M, Campos-Moller X, Saheb H, Ahmed IIK. Efficacy and Adverse Event Profile of the iStent and iStent Inject Trabecular Micro-bypass for Open-angle Glaucoma: A Meta-analysis. J Curr Glaucoma Pract 2018;12(2):67-84.Keywords
This publication has 41 references indexed in Scilit:
- Implantation of trabecular micro-bypass stent using a novel “landing strip” techniqueInternational Journal of Ophthalmology, 2017
- Safety and Efficacy of Two Trabecular Micro-Bypass Stents as the Sole Procedure in Japanese Patients with Medically Uncontrolled Primary Open-Angle Glaucoma: A Pilot Case SeriesJournal of Ophthalmology, 2017
- Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient populationClinical Ophthalmology, 2016
- Outcomes after combined phacoemulsification and trabecular microbypass stent implantation in controlled open-angle glaucomaJournal of Cataract & Refractive Surgery, 2016
- iStent as a Solo Procedure for Glaucoma Patients: A Systematic Review and Meta-AnalysisPLOS ONE, 2015
- Evaluating the Trabecular Micro-Bypass Stent Combined with Phacoemulsification Compared to Phacoemulsification AloneKlinische Monatsblätter für Augenheilkunde, 2015
- Projected Cost Comparison of Trabectome, iStent, and Endoscopic Cyclophotocoagulation Versus Glaucoma Medication in the Ontario Health Insurance PlanJournal of Glaucoma, 2014
- Treatment Outcomes in the Ahmed Baerveldt Comparison Study after 1 Year of Follow-upOphthalmology, 2011
- Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucomaJournal of Cataract & Refractive Surgery, 2010
- Factors for progression and glaucoma treatment: The Early Manifest Glaucoma TrialCurrent Opinion in Ophthalmology, 2004